Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

READ THE FULL STORY:'First time in the world': Nebraska Medicine pilots groundbreaking MS clinical trial CHECK OUT KETV:Get ...

Company opts not to advance VX-993 into pivotal development after Phase II data show no statistically significant benefit ...

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...

Researchers at the University of New Mexico are preparing to launch a phase 1 clinical trial for an Alzheimer's vaccine after ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

Raytone Biotech has successfully treated the first patient in its clinical trial of RTP-008 for the treatment of dry eye ...

The Allan Labor Government has welcomed a new BioNTech clinical trial platform that will provide cancer patients with easier access to the next ...

In a world where a trace of peanut could send some adults to the emergency room, a major breakthrough is offering new hope. A ...

Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and ...

First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval ...

Mary Pat Mirus, 72, realized her balance was suffering, and she struggled to move around without support. A new procedure in ...